On 3 September 2026 Steakholder Foods put five plant-based SKUs onto shelves in the northeastern United States through KeHE Distributors, and described itself in the accompanying press release as “a global leader in 3D-printing technology for production of whole cuts of plant-based meat.”

Nine days earlier the company had furnished its unaudited interim accounts to the SEC. They show no revenue for the six months to 30 June 2026, $264,000 of cost of goods sold against that nil revenue, $1,056,000 of cash, and an explicit statement that the cash balance “is not sufficient to continue the Company’s operations for at least 12 months, which raises substantial doubt about the Company’s ability to continue as a going concern.”

Those two documents are nine days apart. This piece reads the second against the first.

The revenue line, four periods running

Steakholder Foods — formerly MeaTech 3D, renamed in July 2022, Nasdaq-listed since March 2021, food-technology operations commenced September 2019 — has the following continuing-operations income statement, taken from the FY2025 Form 20-F and the H1 2026 interim accounts. All figures are US dollars in thousands, as filed.

FY2023 FY2024 FY2025 H1 2026
Revenue 10
Cost of revenue / goods sold 22 264
Gross profit (loss) (12) (264)
Research and development, net 7,095 3,518 2,189 844
Marketing 1,937 1,192 774 590

The 20-F’s own management discussion puts it plainly: “Revenue decreased by approximately $0.01 million, or 100%, to $0 million for the year ended December 31, 2025, compared to approximately $0.01 million for the year ended December 31, 2024.” Elsewhere it states that “[o]ur initial revenues were generated in late 2024”.

So across three full years and one half-year, total revenue from continuing operations is $10,000, all of it in 2024, and it carried $22,000 of cost. The accumulated deficit at 30 June 2026 is $93,237,000.

There is one other revenue figure in the file, and it belongs to a business the company no longer holds. Twine, treated as a discontinued operation, contributed $248,000 of revenue in 2025 with a net loss of $830,000, and disposal produced a $2,856,000 loss on disposal of assets and liabilities.

Practical consequence: any model of this company that starts from a revenue base is starting from $10,000. Coverage that frames the retail launch as scaling should be read against a denominator of zero.

Cost of goods sold without goods sold

The H1 2026 statement of comprehensive loss records $264,000 of cost of goods sold and a gross loss of exactly the same amount. In the same period, inventory appears on the balance sheet for the first time — $67,000 at 30 June 2026, against nil at 31 December 2025 — and the cash flow statement shows a $67,000 working-capital outflow for the change in inventory.

The accounts do not explain the composition of the $264,000. What is visible is that the company began carrying inventory in the first half of 2026, in the run-up to a retail launch, while recognising close to four dollars of cost of goods sold for every dollar of inventory it capitalised, and recognising all of it against no sales at all.

Practical consequence: for a first-year CPG entrant, the informative number is not the launch count of SKUs but the ratio of pre-launch cost recognition to inventory carried. Here it is roughly 4:1 against inventory, with no revenue on the other side.

The runway arithmetic

Measure (H1 2026 unless stated) Value
Net cash used in operating activities $3,305,000
Implied monthly operating burn ~$551,000
Cash and cash equivalents at 30 June 2026 $1,056,000
Cash at 31 December 2025 $3,087,000
Total comprehensive loss $3,293,000
Total assets $3,147,000
Total shareholders’ equity $2,270,000
Accumulated deficit $93,237,000

At the half-year burn rate, the cash on the balance sheet at 30 June represented under two months of operations. On 31 July the company signed a securities purchase agreement with a single accredited investor; the offering closed on 3 August. It comprised pre-funded warrants over 1,750,000 ADSs at a combined price of $1.99, together with series E and series F warrants each over a further 1,750,000 ADSs at a $2.00 exercise price. Gross proceeds, before placement agent fees and expenses and assuming full exercise of the pre-funded warrants, were “approximately $3.5 million”.

Against a $551,000 monthly operating burn, $3.5 million gross is roughly six months — and that is before the incremental working capital a five-SKU retail launch consumes, and before fees. The series E and F warrants are not funded; they are only exercisable on or after shareholders approve an increase in authorised share capital.

Note also what the operating expense lines did while this was happening. Research and development fell 27% year on year, to $844,000. Marketing rose 63%, to $590,000. General and administrative fell 15%, to $1,626,000. That is a company reallocating a shrinking budget from developing machines toward selling packets.

Dilution, and what an ADS now represents

Date Ordinary shares issued and outstanding
31 December 2024 349,603,759
30 June 2025 915,704,159
31 December 2025 5,438,836,659
30 June 2026 7,794,516,659

Weighted average shares outstanding were 544,608,702 in H1 2025 and 6,780,167,748 in H1 2026 — a factor of 12.4 in twelve months. The reported net loss per share fell from $0.0071 to $0.0005 not because losses shrank but because the denominator grew.

The depositary ratio has moved with it. The FY2025 Form 20-F, filed 30 April 2026, states on its cover and again at Item 12.D that each American Depositary Share represents 4,000 ordinary shares. The 6-K describing the 31 July 2026 purchase agreement describes each ADS as representing twelve thousand (12,000) ordinary shares. Both are primary filings four months apart; the ratio tripled between them.

The 20-F also discloses that Nasdaq filed a rule proposal with the SEC on 26 January 2026 that would permit immediate suspension and delisting of a Nasdaq Capital Market company whose market value of listed securities remains below $5 million for 30 consecutive business days, and states that “[a]s of the date hereof, our market value of listed securities is below $5 million”.

The throughput number is not in the annual report

Steakholder’s identity in trade coverage rests on printer throughput. The MX200 meat printer page states, in three separate places, a production output of “up to 420kg/hour”. The HD144 fish printer page states “up to 100kg/hour”. Those two figures are what circulate.

The Form 20-F does not contain either. What it says is: “Our commercial-scale production machines are being designed to be modular, scalable starting from minimal production capacity of up to a few hundred kilograms per hour.” Every load-bearing word in that sentence is weaker than the marketing figure — a design intention, a starting point, a range rather than a number. The word “throughput” appears twice in the annual report, both times in aspirational or competitive-landscape framing, and neither time attached to a quantity.

One further caution about relying on the product pages. The MX200 page’s FAQ contains the sentence “Its capability to consistently produce 100 kg of product per hour allows it to meet the needs of large food manufacturing operations” — word-for-word the same sentence that appears in the HD144 page’s FAQ. On the MX200 page it sits below a headline claim of 420 kg/hour. We read this as duplicated copy rather than a competing specification, but it is a reminder that the 420 kg/hour figure has never been put in a document the company signs.

Practical consequence: a co-manufacturer sizing a line around 420 kg/hour is sizing it around a marketing page. The number that has been filed under an executive signature is “a few hundred kilograms per hour”, of machines “being designed”. Ask for a witnessed run rate on the specific premix before contracting, as we argued in our analysis of stated bioreactor throughput gains.

The pattern this fits

Steakholder’s original model sold machines, premix blends, brokerage of materials and consulting — four revenue streams the 20-F still lists. The Perfecta launch is a different business: own brand, own inventory, a distributor, and retail margin. Moving downstream when the upstream market does not arrive is a recognisable move, and we have documented what the destination looks like — in the Believer Meats post-mortem, in No Meat Factory’s WARN notice, and in NotCo’s four market exits. None of those companies was short of distribution. They were short of margin.

The structural difficulty is that selling equipment and selling CPG demand opposite balance sheets. Equipment is lumpy, high-margin, low-working-capital and sold to a handful of buyers. CPG is thin-margin, working-capital hungry, and needs sustained trade spend before any velocity data exists. A company with $1.06m of cash, a going-concern qualification and a marketing line of $590,000 for a half-year is attempting the second with the resources of neither. The MAASH capital-structure mismatch we examined last week is the same shape at a different point in the chain.

The counter-argument

A fair reading in the company’s favour runs like this. Zero revenue in H1 2026 is exactly what you would expect from a business that shipped its first retail product in September; the revenue belongs to H2. The $264,000 of cost of goods sold is pre-production expenditure that a going concern must expense, not evidence of loss-making sales. Cash of $1.06m at 30 June is a point-in-time figure superseded by the 3 August closing. Going-concern language is close to universal among clinical-stage-equivalent listed companies and says more about the twelve-month lookforward test than about imminent failure. And the marketing/R&D reallocation is precisely what a company should do when it stops developing and starts selling.

Each of those is true. What they do not answer is the seven-year record: a company that commenced operations in 2019 and has recognised $10,000 of revenue from continuing operations across 2023, 2024, 2025 and the first half of 2026, against an accumulated deficit of $93.2 million. The launch may well produce a revenue line for the first time. The question the filings pose is whether six months of funded runway is enough to find out.

What we could not establish

  • What the $264,000 of cost of goods sold comprises. The interim accounts give no breakdown and no accounting-policy note explaining recognition against nil revenue. Write-down, idle capacity, pre-launch production and trial costs are all consistent with the disclosure; we cannot distinguish them and have not guessed.
  • When the ADS ratio changed from 4,000 to 12,000, and by what mechanism. Both figures are from primary filings four months apart. We did not locate the filing that effected the change.
  • Net proceeds of the August placement. The 6-K gives gross proceeds of “approximately $3.5 million” before placement agent fees and expenses. Net is not disclosed. Our runway arithmetic uses the gross figure and therefore overstates runway.
  • Whether the Nasdaq $5 million MVLS rule proposal has been approved. The 20-F describes it as filed on 26 January 2026 and states the company’s own MVLS was then below $5 million. We have not confirmed its current status or the company’s current MVLS.
  • The provenance of the 420 kg/hour figure. It appears on the company’s product page and in secondary coverage. We found no filed document containing it, and no published test protocol, premix, or duty cycle behind it.
  • Number of retail doors, unit pricing, and KeHE terms. The press release says “retail locations across the Northeastern United States” without a count. No price, margin or listing fee is disclosed anywhere in the filings.
  • Whether any MX200 or HD144 unit has been sold and installed at a third-party site. The FY2024 revenue of $10,000 is too small to represent a machine sale, but the filings do not disaggregate it.

What to watch

  1. The FY2026 interim or annual filing carrying H2 2026. This is the first period in which Perfecta revenue can appear. A number below roughly $250,000 would leave Twine — a disposed business — as the company’s largest revenue event on record.
  2. Whether the going-concern paragraph survives the next set of accounts. The August raise does not obviously clear the twelve-month test on its own.
  3. The shareholder vote on increasing authorised share capital. Series E and F warrants over 3.5 million ADSs cannot be exercised until it passes; it is also the gate on the next financing.
  4. Any disclosure of a witnessed throughput figure in a filed document. That single number would resolve the gap between “420 kg/hour” and “a few hundred kilograms per hour… being designed”.
  5. Whether a machine sale is ever separately disclosed. The pivot to own-brand CPG is only a pivot if the equipment business is being wound down; the filings still list it as a revenue stream.